InvestorsHub Logo
Followers 149
Posts 17898
Boards Moderated 0
Alias Born 04/12/2012

Re: None

Thursday, 04/12/2018 9:47:43 AM

Thursday, April 12, 2018 9:47:43 AM

Post# of 5873
BRIEF-Immunocellular Therapeutics Announces Achievement Of Next Key Milestone In Stem-To-T-Cell Research Immuno Oncology Program
REUTERS 4:10 AM ET 4/12/2018

April 12 (Reuters) - ImmunoCellular Therapeutics Ltd(IMUC/WS) :

* IMMUNOCELLULAR THERAPEUTICS ANNOUNCES ACHIEVEMENT OF NEXT KEY MILESTONE IN STEM-TO-T-CELL RESEARCH IMMUNO-ONCOLOGY PROGRAM

* BEEN ABLE TO VERIFY SUCCESSFUL TRANSFER OF SELECTED T CELL RECEPTOR GENETIC MATERIAL INTO HUMAN HEMATOPOIETIC STEM CELLS Source text for Eikon: Further company coverage:


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IMUC News